SCHEMBL6320852

SCHEMBL6320852

O=C1Cc2cc(C(CNc3cnc4ccccc4c3)P3(=O)OCCO3)ccc2N1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP2 O95551 1/20 0.37
CDK2 P24941 2/20 0.35
CDC7 O00311 1/20 0.35
CCNE1 P24864 1/20 0.35
DBF4 Q9UBU7 1/20 0.35
PTK2 Q05397 6/20 0.35
PTK2B Q14289 4/20 0.35
JAK3 P52333 1/20 0.34
IRAK4 Q9NWZ3 1/20 0.34
KDM4E B2RXH2 2/20 0.34
NPC1 O15118 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
HPGD P15428 1/20 0.34
HTT P42858 1/20 0.34
RAB9A P51151 1/20 0.34
GFER P55789 1/20 0.34
BCL6 P41182 2/20 0.33
FGFR1 P11362 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6325709 0.89 PTK2 (0.37) TDP2CDK2CDC7CCNE1DBF4
SCHEMBL6317759 0.84 OPRM1 (0.38) TDP2CDK2CDC7CCNE1DBF4
SCHEMBL6324395 0.83 BRD4 (0.35) TDP2CDK2CDC7CCNE1DBF4
SCHEMBL6319893 0.82 PTK2 (0.35) TDP2CDK2CDC7CCNE1DBF4
SCHEMBL6317290 0.81 FGFR1 (0.35) TDP2PTK2PTK2BJAK3IRAK4
SCHEMBL6325319 0.76 KDR (0.44) KDM4ENPC1SMN1; SMN2ALDH1A1LMNA
SCHEMBL6325622 0.70 EPHX2 (0.34) CDK2CDC7CCNE1DBF4PTK2
SCHEMBL6320162 0.69 PTK2 (0.35) TDP2CDK2CDC7CCNE1DBF4
SCHEMBL6325348 0.68 GRIA1 (0.32) CDK2CDC7CCNE1DBF4PTK2
SCHEMBL6320139 0.68 ALPL (0.40) KDM4ENPC1SMN1; SMN2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050143349-A1 Phosphorus containing compounds useful for the regulation of LDL and Lp(a) levels QUATRX PHARMACEUTICALS CO. 2005-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050143349-A1 Phosphorus containing compounds useful for the regulation of LDL and Lp(a) levels APOB, LDLR, LPL TDP2 3606/4885CDK2 1197/4885CDC7 4792/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.